Literature DB >> 24034854

Low-dose mirtazapine in treatment of major depression developed following severe nausea and vomiting during pregnancy: two cases.

Faruk Uguz1.   

Abstract

This report presents the successful use of low-dose mirtazapine in the treatment of major depression that developed following severe nausea and vomiting symptoms during the early gestational weeks in two cases. The psychiatric diagnosis was determined with the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Assessments were performed with the Clinical Global Impression-Improvement Scale and the 17-item Hamilton Rating Scale for Depression. Further large-scale studies should be carried out to confirm the useful effects observed in these cases.
© 2014.

Entities:  

Keywords:  Antidepressants; Mirtazapine; Pregnancy; Women

Mesh:

Substances:

Year:  2013        PMID: 24034854     DOI: 10.1016/j.genhosppsych.2013.07.016

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  4 in total

Review 1.  Treatment options for hyperemesis gravidarum.

Authors:  Amy Abramowitz; Emily S Miller; Katherine L Wisner
Journal:  Arch Womens Ment Health       Date:  2017-01-09       Impact factor: 3.633

2.  Effective Treatment of Insomnia With Mirtazapine Attenuates Concomitant Suicidal Ideation.

Authors:  Kamal Gandotra; Peijun Chen; George E Jaskiw; P Eric Konicki; Kingman P Strohl
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

3.  Use of Mirtazapine and Olanzapine in the Treatment of Refractory Hyperemesis Gravidarum: A Case Report and Systematic Review.

Authors:  Marco Aurélio Knippel Galletta; Vera Lucia Carvalho Tess; Isabela Marangon Pasotti; Luiza Fior Pelegrini; Nicole Kemberly Ribeiro Rocha; Carolina Burgarelli Testa; Rossana Pulcineli Vieira Francisco
Journal:  Case Rep Obstet Gynecol       Date:  2022-09-05

4.  Validating the effect of Ondansetron and Mirtazapine In Treating hyperemesis gravidarum (VOMIT): protocol for a randomised placebo-controlled trial.

Authors:  Anne Ostenfeld; Tonny Studsgaard Petersen; Tina Bergmann Futtrup; Jon Trærup Andersen; Andreas Kryger Jensen; Hanne Brix Westergaard; Lars Henning Pedersen; Ellen Christine Leth Løkkegaard
Journal:  BMJ Open       Date:  2020-03-24       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.